Literature DB >> 8202006

Vaccine prophylaxis of Q fever. A follow-up study of the efficacy of Q-Vax (CSL) 1985-1990.

J R Ackland1, D A Worswick, B P Marmion.   

Abstract

OBJECTIVES: To examine the efficacy of various batches of a formalin-inactivated whole cell Coxiella burnetti vaccine (Henzerling strain, Phase 1 [Q-Vax, CSL]) in the prevention of Q fever among abattoir workers. DESIGN AND
SETTING: The study was a retrospective cohort survey of all employees at three South Australian abattoirs to determine the incidence of Q fever among vaccinated and unvaccinated employees during the period 1985 to 1990.
RESULTS: There were two cases of Q fever among 2555 vaccinated employees of the three abattoirs, compared with 55 cases among 1365 unvaccinated employees. The two Q fever cases in vaccinated employees were within a few days of vaccination, before immunity had developed, and represented a coincidence of natural infection and vaccination. Protective efficacy was 100%, even with a batch of Q-Vax containing 20 micrograms/dose rather than the standard dose of 30 micrograms/dose.
CONCLUSIONS: Vaccination was effective for at least five years, although it was uncertain whether this was due to the vaccine per se or to a combination of vaccine immunity reinforced by periodic natural exposure.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8202006

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  26 in total

1.  Q fever seroprevalence in metropolitan samples is similar to rural/remote samples in Queensland, Australia.

Authors:  S J Tozer; S B Lambert; T P Sloots; M D Nissen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-16       Impact factor: 3.267

2.  Eosinophils Affect Antibody Isotype Switching and May Partially Contribute to Early Vaccine-Induced Immunity against Coxiella burnetii.

Authors:  Lindsey Ledbetter; Rama Cherla; Catherine Chambers; Yan Zhang; Guoquan Zhang
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

3.  Coxiella burnetii Blocks Intracellular Interleukin-17 Signaling in Macrophages.

Authors:  Tatiana M Clemente; Minal Mulye; Anna V Justis; Srinivas Nallandhighal; Tuan M Tran; Stacey D Gilk
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

4.  Clinical and pathologic changes in a guinea pig aerosol challenge model of acute Q fever.

Authors:  K E Russell-Lodrigue; G Q Zhang; D N McMurray; J E Samuel
Journal:  Infect Immun       Date:  2006-11       Impact factor: 3.441

5.  Coxiella burnetii - Pathogenic Agent of Q (Query) Fever.

Authors:  Lutz Gürtler; Ursula Bauerfeind; Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Ruth Offergeld; Georg Pauli; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen
Journal:  Transfus Med Hemother       Date:  2013-12-23       Impact factor: 3.747

6.  Development of a lipopolysaccharide-targeted peptide mimic vaccine against Q fever.

Authors:  Ying Peng; Yan Zhang; William J Mitchell; Guoquan Zhang
Journal:  J Immunol       Date:  2012-10-10       Impact factor: 5.422

Review 7.  Adaptive immunity to the obligate intracellular pathogen Coxiella burnetii.

Authors:  Jeffrey G Shannon; Robert A Heinzen
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

Review 8.  Preventive occupational health interventions in the meat processing industry in upper-middle and high-income countries: a systematic review on their effectiveness.

Authors:  Berry J van Holland; Remko Soer; Michiel R de Boer; Michiel F Reneman; Sandra Brouwer
Journal:  Int Arch Occup Environ Health       Date:  2014-08-07       Impact factor: 3.015

9.  Coxiella burnetii seroprevalence of shepherds and their flocks in the lower Saint-Lawrence River region of Quebec, Canada.

Authors:  Patrick Dolcé; Marie-Joële Bélanger; Krzysztof Tumanowicz; Claude P Gauthier; Philippe Jutras; Richard Massé; Claude Montpetit; Harold Bernatchez; Dorothy McColl; Harvey Artsob
Journal:  Can J Infect Dis       Date:  2003-03

10.  Low-dose priming before vaccination with the phase I chloroform-methanol residue vaccine against Q fever enhances humoral and cellular immune responses to Coxiella burnetii.

Authors:  David M Waag; Marilyn J England; Christopher R Bolt; Jim C Williams
Journal:  Clin Vaccine Immunol       Date:  2008-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.